<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Geriatr</journal-id><journal-id journal-id-type="iso-abbrev">BMC Geriatr</journal-id><journal-title-group><journal-title>BMC Geriatrics</journal-title></journal-title-group><issn pub-type="epub">1471-2318</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23009149</article-id><article-id pub-id-type="pmc">3490887</article-id><article-id pub-id-type="publisher-id">1471-2318-12-58</article-id><article-id pub-id-type="doi">10.1186/1471-2318-12-58</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A pilot randomized controlled trial to improve geriatric frailty</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Chan</surname><given-names>Ding-Cheng Derrick</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>doctord6226@yahoo.com</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Tsou</surname><given-names>Hsiao-Hui</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>tsouhh@nhru.org.tw</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Yang</surname><given-names>Rong-Sen</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>rsyang@ntuh.gov.tw</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Tsauo</surname><given-names>Jau-Yih</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>jytsauo@ntu.edu.tw</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Chen</surname><given-names>Ching-Yu</given-names></name><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I5">5</xref><email>chency@nhri.org.tw</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Hsiung</surname><given-names>Chao Agnes</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>hsiung@nhru.org.tw</email></contrib><contrib contrib-type="author" corresp="yes" id="A7"><name><surname>Kuo</surname><given-names>Ken N</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>kennank@aol.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Geriatrics and Gerontology, and Department of Internal Medicine, National Taiwan University Hospital, No.7, ChongSan S. Rd, Taipei, Taiwan</aff><aff id="I2"><label>2</label>Department of Orthopaedics, National Taiwan University Hospital, No.7, ChongSan S. Rd, Taipei, Taiwan</aff><aff id="I3"><label>3</label>School and Graduate Institute of Phsical Therapy, College of Medicine, National Taiwan University, Taipei, Taiwan. Institution mailing address, Floor 3, No. 17, Xuzhou Rd, Taipei, Taiwan</aff><aff id="I4"><label>4</label>Department of Family Medicine, National Taiwan University Hospital, Taipei, No 7 ChungSan S. Rd, Taipei, Taiwan</aff><aff id="I5"><label>5</label>Institute of Population Health Sciences, National Health Research Institutes, R440, 4&#x02009;F, No. 17 Xu-Zhou Road, Taipei, Taiwan</aff><aff id="I6"><label>6</label>Division of Biostatistics and Bioinformatics, Institute of Population Health Sciences, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli County, Taiwan</aff><aff id="I7"><label>7</label>Institute of Population Health Sciences, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli County, Taiwan</aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>25</day><month>9</month><year>2012</year></pub-date><volume>12</volume><fpage>58</fpage><lpage>58</lpage><history><date date-type="received"><day>22</day><month>2</month><year>2012</year></date><date date-type="accepted"><day>11</day><month>9</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2012 Chan et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Chan et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2318/12/58"/><abstract><sec><title>Background</title><p>Few randomized controlled trials (RCTs) report interventions targeting improvement of frailty status as an outcome.</p></sec><sec><title>Methods</title><p>This RCT enrolled 117 older adults (65-79&#x02009;years of age) in Toufen, Taiwan who scored 3-6 on The Chinese Canadian Study of Health and Aging Clinical Frailty Scale Telephone Version and then score &#x02265;1 on the Cardiovascular Health Study Phenotypic Classification of Frailty (CHS_PCF). With a two by two factorial design, subjects were randomly assigned to interventions (Exercise and nutrition, EN, n&#x02009;=&#x02009;55 or problem solving therapy, PST, n&#x02009;=&#x02009;57) or controls (non-EN, n&#x02009;=&#x02009;62 or non-PST, n&#x02009;=&#x02009;60). Educational booklets were provided to all. EN group subjects received nutrition consultation and a thrice-weekly exercise-training program while PST group subjects received 6 sessions in 3&#x02009;month. Subjects were followed at 3, 6, and 12&#x02009;months. Primary outcome was improvement of the CHS_PCF by at least one category (from pre-frail to robust, or from frail to pre-frail or robust) from baseline assessments. One hundred and one completed final assessments. Intention-to-treat analysis with the generalized estimating equation model was applied with adjustment for time and treatment-by-time interactions.</p></sec><sec><title>Results</title><p>Mean age was 71.4&#x02009;&#x000b1;&#x02009;3.7&#x02009;years, with 59% females. Baseline characteristic were generally comparable between groups. EN group subjects had a higher improvement rate on the primary outcome than non-EN group subjects (45% vs 27%, adjusted p&#x02009;=&#x02009;0.008) at 3&#x02009;months, but not 6 or 12&#x02009;months. They also had more increase of serum 25(OH) vitamin D level (4.9&#x02009;&#x000b1;&#x02009;7.7 vs 1.2&#x02009;&#x000b1;&#x02009;5.4, p&#x02009;=&#x02009;0.006) and lower percentage of osteopenia (74% vs 89% p&#x02009;=&#x02009;0.042) at 12&#x02009;months. PST group subjects had better improvement (2.7&#x02009;&#x000b1;&#x02009;6.1 vs 0.2&#x02009;&#x000b1;&#x02009;6.7, p&#x02009;=&#x02009;0.035, 6-month) and less deterioration (&#x02212;3.5&#x02009;&#x000b1;&#x02009;9.7 vs &#x02212;7.1&#x02009;&#x000b1;&#x02009;8.7, p&#x02009;=&#x02009;0.036, 12-month) of dominant leg extension power than non-PST subjects. Some secondary outcomes were also improved in control groups (non-EN or non-PST). No adverse effects were reported.</p></sec><sec><title>Conclusions</title><p>The three-month EN intervention resulted in short-term (3-month) frailty status improvement and long-term effect on bone mineral density and serum vitamin D (12-month) among Taiwanese community-dwelling elders. The effect of PST was less pronounce.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.gov: EC0970301</p></sec></abstract><kwd-group><kwd>Frailty</kwd><kwd>Aged</kwd><kwd>Intervention</kwd><kwd>Effectiveness</kwd><kwd>Community</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Frailty is a geriatric condition characterized by loss of reserves (energy, physical ability, cognition, health) that gives rise to vulnerability 
[<xref ref-type="bibr" rid="B1">1</xref>]. The lack of a consensus, however, on the definitions of and measurements for this geriatric condition has limited comparisons on the effectiveness of interventional studies on frail older adults 
[<xref ref-type="bibr" rid="B2">2</xref>]. Numerous instruments were developed to measure frailty. A recent review of on frailty instruments as outcome measures found that instruments could generally fit into 3 dimensions (physical, psychological, and social) with 8 factors (nutritional status, physical activity, mobility, energy, strength, cognition, mood, and social relationship/social support) 
[<xref ref-type="bibr" rid="B3">3</xref>]. However, it is not clear whether these instruments had sound clinimetric properties to be considered as good outcome measures that were responsive to interventions 
[<xref ref-type="bibr" rid="B3">3</xref>]. Another recent review on exercise interventions for management of frailty also pointed out that even all 47 studied enrolled &#x0201c;frail&#x0201d; older adults, validated operationalizations of frailty were only available for 3 studies 
[<xref ref-type="bibr" rid="B4">4</xref>]. None of the studies reviewed used frailty status as an outcome measure 
[<xref ref-type="bibr" rid="B4">4</xref>]. When we conducted a systemic review of frailty intervention focusing on trials that measured outcomes based on their pre-defined frailty indicators, only 11 studies were included 
[<xref ref-type="bibr" rid="B5">5</xref>]. Of the 4 studies 
[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>] that enrolled participants based on the Cardiovascular Health Study Phenotypic Classification of Frailty (CHS_PCF) 
[<xref ref-type="bibr" rid="B9">9</xref>], one have not published their study outcome 
[<xref ref-type="bibr" rid="B2">2</xref>], and the rests 
[<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>] were not able to demonstrate the effects of interventions on indicators from the CHS_PCF.</p><p>Frailty has multiple etiologies, interacting pathogeneses, and often linked with other geriatric conditions and poor outcomes 
[<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. For example, a recent review found consistent bidirectional associations between depression and frailty in cross-sectional studies, but less consistent associations in cohort studies 
[<xref ref-type="bibr" rid="B12">12</xref>]. Similarly, osteoporosis and frailty shared many common risk factors &#x02014; such as malnutrition, sarcopenia, physical inactivity, and low vitamin D 
[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>] &#x02014; that would increase the risk of fall and fracture 
[<xref ref-type="bibr" rid="B14">14</xref>].</p><p>However, it is not clear whether interventions targeting frailty or other geriatric conditions (eg: depression or osteoporosis) may benefit from each other.</p><p>We designed a pilot randomized control trail using validated frailty indicators to enroll 117 community-dwelling older adults with the following aims: 1) To determine whether the proposed interventions may have an impact on dynamic changes of frailty indicators. 2) To determine whether these interventions have impacts on other outcomes including depression, cognition, bone mineral density, physical function, and quality of life. 3) To explore the feasibility and accurate sample size to inform the design and implementation of future large scale clinical trial.</p></sec><sec sec-type="methods"><title>Methods</title><p>A single site randomized controlled trial was conducted with a 3-month interventions and a 12-month follow-up period after baseline assessments on Taiwanese older adults with high frailty risk (Figure 
<xref ref-type="fig" rid="F1">1</xref>). The study was approved in 2008 by the Institutional Review Board of the National Health Research Institutes (NHRI), Zhunan, Taiwan.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flow chart.</p></caption><graphic xlink:href="1471-2318-12-58-1"/></fig><sec><title>Recruitment and eligibility</title><p>Participants were enrolled after a telephone interview screening followed by a hospital screening. Our target population was community-dwelling older adults from 65 to 79&#x02009;years of age in Toufen Township (N&#x02009;=&#x02009;6,828). The Chinese Canadian Study of Health and Aging Clinical Frailty Scale Telephone Version (CCSHA_CFS_TV) 
[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B16">16</xref>] with satisfactory inter-rater reliability and criterion validity was used for the first stage screening. The instrument was particularly useful in population base screening for its short administration time (&#x0003c;3&#x02009;min) and its easy implementation even by interviewers without formal training in geriatric care 
[<xref ref-type="bibr" rid="B16">16</xref>]. Eligible participants were those scored 3-6 on the CCSHA_CFS_TV. Exclusion criteria included institutionalizations; communication barriers; and scores of 1, 2, (too healthy) or 7 (too ill) on the CCSHA_CFS_TV.</p><p>Eligible older adults were invited to a local community hospital for second-stage screening during their annual geriatric health exams that included history and physical, blood works such as complete blood counts and blood chemistry. Informed consents were signed after careful explanations of the benefits and risks of proposed study. Participants were also asked to give permissions to use information gathered from the geriatric health exams as well as other blood works (such as 25(OH) vitamin D), or special tests (such as bone mineral density) needed from the study.</p><p>The CHS_PCF was used to select eligible participants 
[<xref ref-type="bibr" rid="B9">9</xref>]. Most cut-points were adapted from the CHS (Please refer to Table 
<xref ref-type="table" rid="T1">1</xref> for detail). Important modifications were:</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>The modified Cardiovascular Health Study_ Phenotypic Classification of Frailty (CHS_PCF) criteria</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left" valign="top"><bold>Characteristics</bold></th><th align="left" valign="top"><bold>Definition</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">Weight loss<hr/></td><td align="left" valign="top">Unintentional weight loss of more than 3&#x02009;kg, or greater than 5% of body weight of the previous year<hr/></td></tr><tr><td align="left" valign="top">Exhaustion<hr/></td><td align="left" valign="top">Based on the Center for Epidemiologic Studies Depression Scale (CES-D). Self-report of either of: &#x0201c;I felt that everything I did was an effort&#x0201d; and &#x0201c;I could not get going.&#x0201d; were at least occasionally or more frequent<hr/></td></tr><tr><td align="left" valign="top">Low activity level<hr/></td><td align="left" valign="top">Based on the Taiwan International Physical Activity Questionnaire Short Form (IPAQ-SF). Weekly energy expenditure for activities &#x02267; 2 metabolic equivalent tasks (METs) of fewer than 383&#x02009;kcal for men and 270&#x02009;kcal for women<hr/></td></tr><tr><td align="left" valign="top">Slowness<hr/></td><td align="left" valign="top">Five-meter walking time, by gender and height:<hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">Men: time &#x02267;7&#x02009;s for height &#x02266; 173&#x02009;cm or time &#x02267; 6&#x02009;s for height&#x02009;&#x0003e;&#x02009;173&#x02009;cm<hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">Women: time &#x02267; 7&#x02009;s for height &#x02266; 159&#x02009;cm or time &#x02267; 6&#x02009;s for height&#x02009;&#x0003e;&#x02009;159&#x02009;cm<hr/></td></tr><tr><td rowspan="3" align="left" valign="top">Weakness<hr/></td><td align="left" valign="top">Grip strength (kg), 3 measurements of the dominant hand from a dynamometer (North Coast Medical Precision Instrument, NC70142), stratified by gender and body mass index (BMI) quartiles:<hr/></td></tr><tr><td align="left" valign="top">Men: &#x02266; 29&#x02009;kg for BMI &#x02266; 24&#x02009;kg/m<sup>2</sup>, &#x02266;30&#x02009;kg for BMI 24.1-26&#x02009;kg/m<sup>2</sup>, &#x02266;30&#x02009;kg for BMI 26.1-28&#x02009;kg/m<sup>2</sup>, &#x02266;32&#x02009;kg for BMI&#x02009;&#x0003e;&#x02009;28&#x02009;kg/m<sup>2</sup><hr/></td></tr><tr><td align="left" valign="top">Women: &#x02266; 17&#x02009;kg for BMI &#x02266; 23&#x02009;kg/m<sup>2</sup>, &#x02266; 17.3&#x02009;kg for BMI 23.1-26&#x02009;kg/m<sup>2</sup>, &#x02266;18&#x02009;kg for BMI 26.1-29&#x02009;kg/m<sup>2</sup>, &#x02266;21&#x02009;kg for BMI&#x02009;&#x0003e;&#x02009;29&#x02009;kg/m<sup>2</sup><hr/></td></tr><tr><td align="left" valign="top">Overall frailty status</td><td align="left" valign="top">Robust: 0 indicator was present. Pre-frail: 1 or 2 indicators were present. Frail: &#x02267; 3 indicators were present</td></tr></tbody></table></table-wrap><p>Weight loss of 3&#x02009;kg (instead of 5&#x02009;kg) was used to adjust for smaller body size for an East Asian population. The Taiwan IPAQ-SF (International Physical Activity Questionnaire Short Form) 
[<xref ref-type="bibr" rid="B17">17</xref>] instead of the Minnesota Leisure Time Physical Activity Questionnaire 
[<xref ref-type="bibr" rid="B18">18</xref>] was used to measure energy expenditure because the former has been validated in Taiwanese populations 
[<xref ref-type="bibr" rid="B17">17</xref>].</p><p>Exclusion criteria included hearing/visual impairments affecting daily activity; cognitive impairment, as defined by a Mini-Mental Status Exam (MMSE) score of &#x02264;16 
[<xref ref-type="bibr" rid="B19">19</xref>]; functional impairment, as defined by a Barthel Index (BI) &#x02264;35 
[<xref ref-type="bibr" rid="B20">20</xref>]; active alcohol-abuse problems, organic mental disorders; history of schizophrenia or a diagnosis of a bipolar disorder; any mental problems (other than depression) under psychiatric care; active suicidal ideation; and a score of 0 on the CHS_PCF 
[<xref ref-type="bibr" rid="B9">9</xref>].</p></sec><sec><title>Measurements and procedures</title><p>Baseline assessments were completed before randomizations. Outcomes were assessed at the end of intervention (roughly 3&#x02009;months after baseline assessments), 6&#x02009;months and 12&#x02009;months after baseline assessments.</p></sec><sec><title>Baseline assessments</title><p>Other than the frailty related characteristics collected from screening stages, comprehensive assessments were performed to collect data on several domains including 1) demographics, 2) health related characteristics, 3) body composition, and musculoskeletal system characteristics, and 4) blood works. Important primary and secondary outcomes were listed below.</p></sec><sec><title>Primary and secondary outcomes</title><p>The primary outcome was improvement of CHS_PCF by at least one category (from pre-frail to robust, or from frail to pre-frail or robust) 
[<xref ref-type="bibr" rid="B9">9</xref>]. Secondary outcomes included interval changes of the following indicators between baseline and repeated assessments. We also categorized secondary outcomes into the above domains. In the frailty index domain, we included each of the 5 indicator from the CHS_PCF 
[<xref ref-type="bibr" rid="B9">9</xref>]. In the health-related characteristics domain, we included the Mini Mental Status Exam (MMSE) 
[<xref ref-type="bibr" rid="B19">19</xref>], Primary Care Evaluation of Mental Disorders (PRIME-MD) score 
[<xref ref-type="bibr" rid="B21">21</xref>], and the Barthel Index (BI) score 
[<xref ref-type="bibr" rid="B20">20</xref>], health care resource utilization, and EQ-5D<sup><italic>TM</italic></sup>[<xref ref-type="bibr" rid="B22">22</xref>]. In the complex body composition and musculoskeletal system domain, we included, body mass index (BMI), fat free mass (FFM) (Inbody 3.0&#x000ae;, as a substitute of lean body mass), lowest T score from either spine or hip bone mineral density (BMD, Norland Excell Bone Densitometer&#x000ae;), left one-leg-stand time, and dominant leg extension power. Finally, for all the blood chemistry we collected, we only reported 25(OH) Vitamin D level as the outcome for this manuscript. Most primary and secondary outcomes were repeated at all follow up visits except for MMSE, BMD, and 25(OH) Vitamin D (only repeated at 12-month). To improve the comparability of the baseline and 12-month 25(OH) Vitamin D samples, we defrosted samples collected at 2 different time-points to run the radioimmunoassay (RIA) on the same kit (DiaSorin&#x000ae;, Minnesota, U.S.A.).</p></sec><sec><title>Randomization</title><p>Subjects were stratified by age (65-74, 75-79) and gender to achieve balance of baseline characteristics. Within each stratum, a permuted block (4 persons/block) randomization method was used to ensure balanced assignments. The randomization code was generated from the off-site statistical center with a computer random number generator. Random group allocation was managed by a project manager not involved in assessment or intervention. In a 2&#x02009;&#x000d7;&#x02009;2 factorial design, subjects were first randomly assigned to an exercise and nutritional program (EN) or non-EN group. Within each group, subjects were further randomized to a problem solving therapy (PST) 
[<xref ref-type="bibr" rid="B23">23</xref>] group or non-PST group. Previous studies have shown that when PST was used, both mental and physical health were improved 
[<xref ref-type="bibr" rid="B23">23</xref>]. The 2&#x02009;&#x000d7;&#x02009;2 factorial design would help to determine the individual effect of two interventions on frailty.</p></sec><sec><title>Blinding</title><p>The research assistants who performed baseline and outcome assessments were blinded from the randomization status. However, blinding to the intervention research assistants or participants was not possible with the designed interventions.</p></sec><sec><title>Interventions</title><sec><title>Education booklet</title><p>The educational booklet on frailty, healthy diets, exercise protocols, and self-coping strategies was given to all participants. Subjects who were randomized into the non-EN, non-PST groups were contacted monthly to check on how much they had read the booklet and how well they had complied with the suggested diet and exercise protocols. For those randomized into EN or PST groups, similar questions were asked during their visits to the study sites for their designated programs</p></sec><sec><title>Exercise and nutritional program</title><p>The EN group subjects were invited to take a structured exercise course at the participating hospital 3 times a week for 3&#x02009;months. Each section lasted about 1&#x02009;h. The exercise program included 15&#x02009;min warm up with 10&#x02009;min brisk walks followed by gentle stretching of major joints (cervical and lumbar joints) and muscles (such as biceps, triceps, hamstrings, rectus femoris, gastrocnemius, soleus) for 5 repetitions each. Resistance training (20-30&#x02009;min) with rubber band and bottled water (0.6-1&#x02009;L) as weight for major muscles of upper and lower limbs with 10 to 15 repetitions for each (such as deltoids, biceps, triceps, hand grasp, hip and knee flexors and extensors, hip abductors, ankle plantar flexors and dorsiflexors). Postural control activities and balance training were also provided for 10&#x02009;min by asking participants to perform tandem gaits and one leg standing with eyes open/close (up to ones&#x02019; ability), step up and down stairs, toe walking and heel walking. Finally a 5-min cool down session with gentle relaxation movements are done. The research team also inquired about the subjects&#x02019; dietary compliance and responded to their dietary questions during the exercise sessions.</p></sec><sec><title>The problem solving therapy</title><p>The PST group subjects received 6 sessions therapy by trained case managers. It is a brief form of evidence-based psychotherapy that was originally developed in Britain for use by medical professionals in primary care. It teaches people how to solve the &#x0201c;here-and-now&#x0201d; problems contributing to their mood-related conditions and helps increase their self-efficacy 
[<xref ref-type="bibr" rid="B23">23</xref>]. Previous studies have shown that when PST was used to manage mental problems, both mental and physical health were improved 
[<xref ref-type="bibr" rid="B23">23</xref>].</p></sec><sec><title>Approaches to analysis</title><p>Data were coded to permit blinding to group allocation during statistical analysis. All statistical analyses were conducted using SAS software, Version 9.1 (SAS Institute, Inc., Cary, NC). Analysis was conducted at baseline and at 3-month, 6-month, and 12-month follow-up assessments in accord with the &#x0201c;intention-to-treat&#x0201d; principle (ITT). Summary statistics, including mean and standard deviation, were provided for continuous variables, such as age, MMSE, PRIME-MD, etc. Frequencies and proportions were used to summarize discrete variables, such as CCSHA_CFS TV, CHS_PCF categorization, etc. Missing variables were excluded from analyses. Baseline characteristics were compared between two groups using <italic>t</italic>-test for continuous variables and chi-square test with Fisher&#x02019;s exact test when appropriate for categorical variables.</p><p>Because of the factorial design, we tested for a possible interaction between the 2 interventions (EN and PST) for each reported outcome. If there was no interaction, we examine the independent effect of one intervention controlling for the effect of the other. If there was significant interaction, we would perform subgroup analysis to report the effect of one intervention with or without the other intervention.</p><p>In our study, the outcomes of interest (e.g., frailty improvement) were measured at several time points (baseline, the 3rd month, the 6th month, and the 12th month). For estimating the repeated measurements of the intervention effect, the generalized estimating equations (GEE) model was used to compare the between-group frailty improvement with adjustment for time and treatment-by-time interactions. GEE approach is an extension of generalized linear model (GLM) and provides a semi-parametric approach to repeated categorical response. The intervention effect can be reasonably estimated by using GEE even if the covariance structure is not specified correctly. The primary outcome was also adjusted for multiple baseline characteristics, including age, gender, MMSE, healthcare-resource utilizations, EQ-5D, FFM, BMD, one-leg stand and 25 (OH) Vitamin D. Where high co-linearity was found between two potential confounders, only one variable was retained in the final model.</p><p>Longitudinal changes between groups and changes within a group were analyzed with the use of linear mixed models. However, the between-group BMD differences were compared using logistic regression model at 12&#x02009;months. Under all circumstances, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered to be statistically significant.</p></sec></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Participant flow</title><p>From the 6,828 target population, the probability-proportional-to-size (PPS) sampling approach was employed to select 2,900 population-representative random samples for first-stage screening. However, only 845 completed the telephone interview, 548 of whom were eligible for second-stage screening. Half (N&#x02009;=&#x02009;275) signed the informed consents and were screened at the hospital. The recruitment period was roughly 3&#x02009;months. Following the 2 by 2 factorial design protocol, 117 out of the 151 eligible subjects were randomized into 4 groups: A (EN/PST), B(EN/non-PST), C(non-EN/PST), and D(non-EN/non-PST). Group A and B were combined into the EN group (N&#x02009;=&#x02009;55) while group C and D were combined into the non-EN group (N&#x02009;=&#x02009;62). Similarly, Group A and C became the PST group (N&#x02009;=&#x02009;57) while group B and D were the non-PST group (N&#x02009;=&#x02009;60). Eighteen of the 55 EN group subjects attended at least 50% of the 36 intervention sessions while 16 of the 57 PST subjects completed the 6 courses. At 12&#x02009;months, 50 (EN group), 51 (non-EN group), 48 (PST group), 53 (non-PST group) subjects completed final assessments, respectively. The reason for attrition was participant refusal (Figure 
<xref ref-type="fig" rid="F1">1</xref>).</p></sec><sec><title>Baseline characteristics</title><p>For the entire cohort (N&#x02009;=&#x02009;117), mean age was 71.4&#x02009;&#x000b1;&#x02009;3.7; and 69 (59%) were female. Using the CCSHA_CFS TV, 47 (40%) were categorized into category 3 (well, with treated co-morbid diseases), 55 (47%) into category 4 (apparently vulnerable), 13 (11%) into category 5 (mildly frail), and 2 (2%) into category 6 (moderately frail). With the CHS_PCF, 102 (87%) were classified pre-frail, and 15 (13%) as frail at baseline.</p><p>Even though all subjects were considered at high risk for frailty, subjects enrolled in the trial were relatively healthy with few co-morbidities (3.5&#x02009;&#x000b1;&#x02009;2.2), preserved BI (mean 98.3&#x02009;&#x000b1;&#x02009;4.7) score, MMSE (24.4&#x02009;&#x000b1;&#x02009;3.9) scores, low PRIME-MD (2.5&#x02009;&#x000b1;&#x02009;3.4) score, satisfactory EQ-5D score (0.9&#x02009;&#x000b1;&#x02009;0.1), and few healthcare-resource utilizations (1.6&#x02009;&#x000b1;&#x02009;2.0). The cohort had high prevalence of radiographic vertebral fracture (N&#x02009;=&#x02009;111, 95%), and high prevalence of osteopenia (n&#x02009;=&#x02009;92, 80%) from DXA scan. The mean left one leg stand time was 5.8&#x02009;&#x000b1;&#x02009;6.3&#x02009;s, the mean dominant leg extension power is 25.7&#x02009;&#x000b1;&#x02009;6.1&#x02009;kg, and the mean 25 (OH) Vitamin D level was 17.5&#x02009;&#x000b1;&#x02009;5.8 (ng/ml).</p><p>Most baseline characteristics were similar between EN and no-EN group, also between PST, and non-PST group (Table 
<xref ref-type="table" rid="T2">2</xref>). However, EN group subjects had lower percentage of weakness (60% vs 81%, p&#x02009;=&#x02009;0.014), higher number of co-morbid conditions (4.0&#x02009;&#x000b1;&#x02009;2.1 vs 3.1&#x02009;&#x000b1;&#x02009;2.2, p&#x02009;=&#x02009;0.022) (Table 
<xref ref-type="table" rid="T2">2</xref>). Also, PST group subjects higher percentage of slowness (26% vs 12%, p&#x02009;=&#x02009;0.043).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Baseline Characteristics of the Participants, Total Patient Number&#x02009;=&#x02009;117</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/></colgroup><thead valign="top"><tr><th rowspan="2" align="left" valign="top"><bold>Characteristics</bold></th><th align="char" valign="top"><bold>EN (N&#x02009;=&#x02009;55)</bold><hr/></th><th align="center" valign="top"><bold>Non-EN (N&#x02009;=&#x02009;62)</bold><hr/></th><th rowspan="2" align="center" valign="top"><bold>P-value</bold>&#x02021;</th><th align="char" valign="top"><bold>PST (N&#x02009;=&#x02009;57)</bold><hr/></th><th align="center" valign="top"><bold>Non-PST (N&#x02009;=&#x02009;60)</bold><hr/></th><th rowspan="2" align="center" valign="top"><bold>P-value</bold>&#x02021;</th></tr><tr><th align="char" valign="top"><bold>n (%) mean &#x000b1; sd</bold>&#x02020;</th><th align="center" valign="top"><bold>n (%) mean &#x000b1; sd</bold>&#x02020;</th><th align="char" valign="top"><bold>n (%) mean &#x000b1; sd</bold>&#x02020;</th><th align="center" valign="top"><bold>n (%) mean &#x000b1; sd</bold>&#x02020;</th></tr></thead><tbody valign="top"><tr><td colspan="7" align="center" valign="top"><bold>Frailty-Related Characteristics</bold><hr/></td></tr><tr><td align="left" valign="top">CCSHA_CFS TV<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;well, with treated co-morbid diseases (3)<hr/></td><td align="char" valign="top" char="(">24 (44)<hr/></td><td align="char" valign="top" char="(">23 (37 )<hr/></td><td align="char" valign="top" char=".">0.719<hr/></td><td align="char" valign="top" char="(">24 (42)<hr/></td><td align="char" valign="top" char="(">23 (38)<hr/></td><td align="char" valign="top" char=".">0.755<hr/></td></tr><tr><td align="left" valign="top">&#x02002;apparently vulnerable (4)<hr/></td><td align="char" valign="top" char="(">25 (45)<hr/></td><td align="char" valign="top" char="(">30 (48)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top" char="(">27 (47)<hr/></td><td align="char" valign="top" char="(">28 (7)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;mildly frail (5) + moderately frail (6)<hr/></td><td align="char" valign="top" char="(">6 (11)<hr/></td><td align="char" valign="top" char="(">9 (15)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top" char="(">6 (11)<hr/></td><td align="char" valign="top" char="(">9 (15)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">CHS_PCF categorization<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;pre-frail (1&#x02013;2)<hr/></td><td align="char" valign="top" char="(">46 (84)<hr/></td><td align="char" valign="top" char="(">56 (90)<hr/></td><td align="char" valign="top" char=".">0.280<hr/></td><td align="char" valign="top" char="(">48 (84)<hr/></td><td align="char" valign="top" char="(">54 (90)<hr/></td><td align="char" valign="top" char=".">0.349<hr/></td></tr><tr><td align="left" valign="top">&#x02002;frail (3&#x02013;5)<hr/></td><td align="char" valign="top" char="(">9 (16)<hr/></td><td align="char" valign="top" char="(">6 (10)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top" char="(">9 (16 )<hr/></td><td align="char" valign="top" char="(">6 (10 )<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">CHS_PCF characteristics<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02003;Weight loss (yes)<hr/></td><td align="char" valign="top" char="(">18 (33)<hr/></td><td align="char" valign="top" char="(">12 (19)<hr/></td><td align="char" valign="top" char=".">0.098<hr/></td><td align="char" valign="top" char="(">12 (21 )<hr/></td><td align="char" valign="top" char="(">18 (3)<hr/></td><td align="char" valign="top" char=".">0.268<hr/></td></tr><tr><td align="left" valign="top">&#x02003;Exhaustion (yes)<hr/></td><td align="char" valign="top" char="(">25 (45 )<hr/></td><td align="char" valign="top" char="(">23 (37)<hr/></td><td align="char" valign="top" char=".">0.359<hr/></td><td align="char" valign="top" char="(">22 (39)<hr/></td><td align="char" valign="top" char="(">26(43)<hr/></td><td align="char" valign="top" char=".">0.603<hr/></td></tr><tr><td align="left" valign="top">&#x02003;Low activity level (yes)<hr/></td><td align="char" valign="top" char="(">3 (5)<hr/></td><td align="char" valign="top" char="(">6 (10)<hr/></td><td align="char" valign="top" char=".">0.498<hr/></td><td align="char" valign="top" char="(">5(9)<hr/></td><td align="char" valign="top" char="(">4(7)<hr/></td><td align="char" valign="top" char=".">0.739<hr/></td></tr><tr><td align="left" valign="top">&#x02003;Slowness (yes)<hr/></td><td align="char" valign="top" char="(">10(18)<hr/></td><td align="char" valign="top" char="(">12(9)<hr/></td><td align="char" valign="top" char=".">0.871<hr/></td><td align="char" valign="top" char="(">15 (26)<hr/></td><td align="char" valign="top" char="(">7 (12)<hr/></td><td align="char" valign="top" char=".">0.043<hr/></td></tr><tr><td align="left" valign="top">&#x02003;Weakness (yes)<hr/></td><td align="char" valign="top" char="(">33 (60)<hr/></td><td align="char" valign="top" char="(">50 (81)<hr/></td><td align="char" valign="top" char=".">0.014<hr/></td><td align="char" valign="top" char="(">42 (74)<hr/></td><td align="char" valign="top" char="(">41 (68)<hr/></td><td align="char" valign="top" char=".">0.524<hr/></td></tr><tr><td colspan="7" align="center" valign="top"><bold>Demographics</bold><hr/></td></tr><tr><td align="left" valign="top">Age (y/o)<hr/></td><td align="char" valign="top" char="&#x000b1;">70.9 &#x000b1; 3.7<hr/></td><td align="char" valign="top" char="&#x000b1;">71.9 &#x000b1; 3.7<hr/></td><td align="char" valign="top" char=".">0.158<hr/></td><td align="char" valign="top" char="(">71.5 &#x000b1;3.7<hr/></td><td align="char" valign="top" char="(">71.3 &#x000b1; 3.9<hr/></td><td align="char" valign="top" char=".">0.673<hr/></td></tr><tr><td align="left" valign="top">Female sex<hr/></td><td align="char" valign="top" char="(">33(60)<hr/></td><td align="char" valign="top" char="(">36(58)<hr/></td><td align="char" valign="top" char=".">0.832<hr/></td><td align="char" valign="top" char="(">33(58)<hr/></td><td align="char" valign="top" char="(">36 (60)<hr/></td><td align="char" valign="top" char=".">0.817<hr/></td></tr><tr><td colspan="7" align="center" valign="top"><bold>Health-Related Characteristics</bold><hr/></td></tr><tr><td align="left" valign="top">Number of chronic conditions<sup>&#x000a7;</sup>(N&#x02009;=&#x02009;114)<hr/></td><td align="char" valign="top" char="&#x000b1;">4.0 &#x000b1; 2.1<hr/></td><td align="char" valign="top" char="&#x000b1;">3.1 &#x000b1; 2.2<hr/></td><td align="char" valign="top" char=".">0.022<hr/></td><td align="char" valign="top" char="&#x000b1;">3.8 &#x000b1; 2.4<hr/></td><td align="char" valign="top" char="&#x000b1;">3.2 &#x000b1; 1.9<hr/></td><td align="char" valign="top" char=".">0.184<hr/></td></tr><tr><td align="left" valign="top">MMSE<hr/></td><td align="char" valign="top" char="&#x000b1;">24.8 &#x000b1; 3.9<hr/></td><td align="char" valign="top" char="&#x000b1;">24.1 &#x000b1; 3.9<hr/></td><td align="char" valign="top" char=".">0.358<hr/></td><td align="char" valign="top" char="&#x000b1;">24.7 &#x000b1; 3.8<hr/></td><td align="char" valign="top" char="&#x000b1;">24.2 &#x000b1; 4.0<hr/></td><td align="char" valign="top" char=".">0.552<hr/></td></tr><tr><td align="left" valign="top">PRIME-MD<hr/></td><td align="char" valign="top" char="&#x000b1;">2.1 &#x000b1; 3.2<hr/></td><td align="char" valign="top" char="&#x000b1;">2.8 &#x000b1; 3.5<hr/></td><td align="char" valign="top" char=".">0.229<hr/></td><td align="char" valign="top" char="&#x000b1;">2.7 &#x000b1; 3.3<hr/></td><td align="char" valign="top" char="&#x000b1;">2.3 &#x000b1; 3.4<hr/></td><td align="char" valign="top" char=".">0.469<hr/></td></tr><tr><td align="left" valign="top">Barthel Index<hr/></td><td align="char" valign="top" char="&#x000b1;">98.8 &#x000b1; 3.7<hr/></td><td align="char" valign="top" char="&#x000b1;">97.9 &#x000b1; 5.4<hr/></td><td align="char" valign="top" char=".">0.284<hr/></td><td align="char" valign="top" char="&#x000b1;">98.2 &#x000b1; 5.4<hr/></td><td align="char" valign="top" char="&#x000b1;">98.4 &#x000b1; 4.0<hr/></td><td align="char" valign="top" char=".">0.846<hr/></td></tr><tr><td align="left" valign="top">EQ-5D<hr/></td><td align="char" valign="top" char="&#x000b1;">0.94 &#x000b1; 0.08<hr/></td><td align="char" valign="top" char="&#x000b1;">0.94 &#x000b1; 0.08<hr/></td><td align="char" valign="top" char=".">0.969<hr/></td><td align="char" valign="top" char="&#x000b1;">0.95 &#x000b1; 0.08<hr/></td><td align="char" valign="top" char="&#x000b1;">0.93 &#x000b1; 0.08<hr/></td><td align="char" valign="top" char=".">0.246<hr/></td></tr><tr><td align="left" valign="top">Healthcare-resource utilization<hr/></td><td align="char" valign="top" char="&#x000b1;">1.5 &#x000b1; 1.7<hr/></td><td align="char" valign="top" char="&#x000b1;">1.7 &#x000b1; 2.2<hr/></td><td align="char" valign="top" char=".">0.517<hr/></td><td align="char" valign="top" char="&#x000b1;">1.6 &#x000b1; 1.7<hr/></td><td align="char" valign="top" char="&#x000b1;">1.7 &#x000b1; 2.2<hr/></td><td align="char" valign="top" char=".">0.846<hr/></td></tr><tr><td colspan="7" align="center" valign="top"><bold>Body Composition, and Musculoskeletal System Characteristics</bold><hr/></td></tr><tr><td align="left" valign="top">BMI (kg/m<sup>2</sup>)<hr/></td><td align="char" valign="top" char="&#x000b1;">25.0 &#x000b1; 3.3<hr/></td><td align="char" valign="top" char="&#x000b1;">25.8 &#x000b1; 3.9<hr/></td><td align="char" valign="top" char=".">0.229<hr/></td><td align="char" valign="top" char="&#x000b1;">25.0 &#x000b1; 3.8<hr/></td><td align="char" valign="top" char="&#x000b1;">25.8 &#x000b1; 3.5<hr/></td><td align="char" valign="top" char=".">0.251<hr/></td></tr><tr><td align="left" valign="top">FFM (kg)<hr/></td><td align="char" valign="top" char="&#x000b1;">42.3 &#x000b1; 7.0<hr/></td><td align="char" valign="top" char="&#x000b1;">43.6 &#x000b1; 7. 9<hr/></td><td align="char" valign="top" char=".">0.345<hr/></td><td align="char" valign="top" char="&#x000b1;">42.2 &#x000b1; 7.3<hr/></td><td align="char" valign="top" char="&#x000b1;">43.7 &#x000b1; 7.6<hr/></td><td align="char" valign="top" char=".">0.275<hr/></td></tr><tr><td align="left" valign="top">Compres sion Fracture form Spine XRAY<hr/></td><td align="char" valign="top" char="(">53 (96)<hr/></td><td align="char" valign="top" char="(">58 (94)<hr/></td><td align="char" valign="top" char=".">0.683<hr/></td><td align="char" valign="top" char="(">54 (95)<hr/></td><td align="char" valign="top" char="(">57 (95)<hr/></td><td align="char" valign="top" char=".">1.000<hr/></td></tr><tr><td align="left" valign="top">BMD (T-score)<sup>&#x02225;</sup> (N&#x02009;=&#x02009;115)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x0003e; &#x02212;1<hr/></td><td align="char" valign="top" char="(">13 (25)<hr/></td><td align="char" valign="top" char="(">10(16)<hr/></td><td align="char" valign="top" char=".">0.262<hr/></td><td align="char" valign="top" char="(">13 (23)<hr/></td><td align="char" valign="top" char="(">10(17)<hr/></td><td align="char" valign="top" char=".">0.401<hr/></td></tr><tr><td align="left" valign="top">&#x02266; &#x02212;1<hr/></td><td align="char" valign="top" char="(">40 (75)<hr/></td><td align="char" valign="top" char="(">52 (84)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top" char="(">43 (77)<hr/></td><td align="char" valign="top" char="(">49 (83)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">Left one leg stand time (sec) (N&#x02009;=&#x02009;111)<hr/></td><td align="char" valign="top" char="&#x000b1;">5.7 &#x000b1; 6.9<hr/></td><td align="char" valign="top" char="&#x000b1;">5.8 &#x000b1; 5.9<hr/></td><td align="char" valign="top" char=".">0.949<hr/></td><td align="char" valign="top" char="&#x000b1;">5.3 &#x000b1; 6.7<hr/></td><td align="char" valign="top" char="&#x000b1;">6.2 &#x000b1; 6.0<hr/></td><td align="char" valign="top" char=".">0.483<hr/></td></tr><tr><td align="left" valign="top">Dominant leg extension power (kg)<hr/></td><td align="char" valign="top" char="&#x000b1;">26.3 &#x000b1; 5.1<hr/></td><td align="char" valign="top" char="&#x000b1;">25.2 &#x000b1; 6.8<hr/></td><td align="char" valign="top" char=".">0.295<hr/></td><td align="char" valign="top" char="&#x000b1;">23.9 &#x000b1; 6.5<hr/></td><td align="char" valign="top" char="&#x000b1;">27.4 &#x000b1; 5.1<hr/></td><td align="char" valign="top" char=".">0.002<hr/></td></tr><tr><td colspan="7" align="center" valign="top"><bold>Blood Examination</bold><hr/></td></tr><tr><td align="left" valign="top">25(OH) Vitamin D (ng/mL) (N&#x02009;=&#x02009;109)</td><td align="char" valign="top" char="&#x000b1;">17.8 &#x000b1; 5.3</td><td align="char" valign="top" char="&#x000b1;">17.2 &#x000b1; 6.2</td><td align="char" valign="top" char=".">0.558</td><td align="char" valign="top" char="&#x000b1;">17.9 &#x000b1; 5.5</td><td align="char" valign="top" char="&#x000b1;">17.2 &#x000b1; 6.0</td><td align="char" valign="top" char=".">0.514</td></tr></tbody></table><table-wrap-foot><p>&#x02020;:Categorical data:n (%);Continuous variables:mean <bold>&#x000b1;</bold> sd.</p><p>&#x02021;:Categorical data:<italic>&#x003c7;</italic><sup>2</sup> test or Fisher&#x02019;s exact test;Continuous variables: <italic>t</italic>-test.</p><p><sup>&#x000a7;</sup>:From 27 diseases.</p><p><sup>&#x000b6;</sup>:Emergency room visits, hospitalizations, or clinic visits in the past 3&#x02009;months.</p><p><sup>&#x02225;</sup>:The minimum T-score of either the femoral neck or the spinal mean at L2&#x02013;L4.</p><p><italic>BMD</italic>:Bone Mineral Density, <italic>BMI</italic>: Body mass index, <italic>CCSHA_CFS TV</italic>:Chinese Canadian Study of Health and Aging_Clinical Frailty Scale Telephone Version, <italic>CHS_PCF</italic>:Cardiovascular Health Study_Phenotypical Classifica tion of Frailty, <italic>EN</italic>:Exercise and Nutrition, <italic>EQ</italic>-5D:EuroQol Quality of Life Scale, <italic>FFM</italic>:Fat Free Mass, <italic>MMSE</italic>:Mini-Mental State Examination, <italic>PRIME-MD</italic>:Primary Care Evaluation of Mental Disorders, <italic>PST</italic>:Problem Solving Therapy.</p></table-wrap-foot></table-wrap></sec><sec><title>Primary outcomes and transition of frailty status</title><p>The improvement rates were highest at the end of intervention (3-month) for EN (45%) and PST (44%) groups. Afterwards, there were gradual declines of the improvement rates at 6 (42% EN group, 35% PST group) and 12 (40%, EN group, 35% PST group) months. On the other hands, the improvement rates of the non-EN, or non-PST group subjects were stable around 30%. Therefore, only the 3-month differences between EN and non-EN group (45% vs 27% p&#x02009;=&#x02009;0.008) was significant after adjusting the effect of PST and other potential confounders (Figure 
<xref ref-type="fig" rid="F2">2</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Primary Outcome.</p></caption><graphic xlink:href="1471-2318-12-58-2"/></fig><p>During the intervention period (baseline to 3-month), 33 (32.4%) of the prefrail participants (N&#x02009;=&#x02009;102) improved to robust, while 3 (20%) and 6(40%) of the frail (N&#x02009;=&#x02009;15) participants improved to robust and prefrail, respectively (Table 
<xref ref-type="table" rid="T3">3</xref>). During follow-up periods without intensive interventions, most individual stayed at their original status, the chances for natural transition to better frailty status was a lot fewer. For example, during the 3-6&#x02009;month follow up period, only 2 (22.2%) of frail individuals (N&#x02009;=&#x02009;9) improved to prefail status, and only 12 (16.7%) of prefrail individuals (N&#x02009;=&#x02009;72) improved to robust status.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Transitions among frailty states at different time points</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="char"/><col align="center"/><col align="char"/><col align="center"/><col align="char"/></colgroup><thead valign="top"><tr><th align="center" valign="top">&#x000a0;</th><th colspan="2" align="center" valign="top"><bold>Baseline to 3&#x02009;months</bold></th><th colspan="2" align="center" valign="top"><bold>3 to 6&#x02009;months</bold></th><th colspan="2" align="center" valign="top"><bold>6 to 12&#x02009;months</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="top">Transition<hr/></td><td align="center" valign="top">No.<hr/></td><td align="center" valign="top">Rate,%<hr/></td><td align="center" valign="top">No.<hr/></td><td align="center" valign="top">Rate,%<hr/></td><td align="center" valign="top">No.<hr/></td><td align="center" valign="top">Rate,%<hr/></td></tr><tr><td align="center" valign="top">Robust to<hr/></td><td align="center" valign="top">-<hr/></td><td align="center" valign="top">-<hr/></td><td colspan="2" align="center" valign="top">N&#x02009;=&#x02009;36<hr/></td><td colspan="2" align="center" valign="top">N&#x02009;=&#x02009;34<hr/></td></tr><tr><td align="center" valign="top">Robust<hr/></td><td align="center" valign="top">-<hr/></td><td align="center" valign="top">-<hr/></td><td align="center" valign="top">22<hr/></td><td align="center" valign="top">61.1<hr/></td><td align="center" valign="top">25<hr/></td><td align="center" valign="top">73.5<hr/></td></tr><tr><td align="center" valign="top">Pre-frail<hr/></td><td align="center" valign="top">-<hr/></td><td align="center" valign="top">-<hr/></td><td align="center" valign="top">13<hr/></td><td align="center" valign="top">36.1<hr/></td><td align="center" valign="top">9<hr/></td><td align="center" valign="top">26.5<hr/></td></tr><tr><td align="center" valign="top">Frail<hr/></td><td align="center" valign="top">-<hr/></td><td align="center" valign="top">-<hr/></td><td align="center" valign="top">1<hr/></td><td align="center" valign="top">2.8<hr/></td><td align="center" valign="top">0<hr/></td><td align="center" valign="top">0.0<hr/></td></tr><tr><td align="center" valign="top">Pre-frail to<hr/></td><td colspan="2" align="center" valign="top">N&#x02009;=&#x02009;102<hr/></td><td colspan="2" align="center" valign="top">N&#x02009;=&#x02009;72<hr/></td><td colspan="2" align="center" valign="top">N&#x02009;=&#x02009;69<hr/></td></tr><tr><td align="center" valign="top">Robust<hr/></td><td align="center" valign="top">33<hr/></td><td align="center" valign="top">32.4<hr/></td><td align="center" valign="top">12<hr/></td><td align="center" valign="top">16.7<hr/></td><td align="center" valign="top">10<hr/></td><td align="center" valign="top">14.5<hr/></td></tr><tr><td align="center" valign="top">Pre-frail<hr/></td><td align="center" valign="top">66<hr/></td><td align="center" valign="top">64.7<hr/></td><td align="center" valign="top">54<hr/></td><td align="center" valign="top">75.0<hr/></td><td align="center" valign="top">58<hr/></td><td align="center" valign="top">84.1<hr/></td></tr><tr><td align="center" valign="top">Frail<hr/></td><td align="center" valign="top">3<hr/></td><td align="center" valign="top">2.9<hr/></td><td align="center" valign="top">6<hr/></td><td align="center" valign="top">8.3<hr/></td><td align="center" valign="top">1<hr/></td><td align="center" valign="top">1.4<hr/></td></tr><tr><td align="center" valign="top">Frail to<hr/></td><td colspan="2" align="center" valign="top">N&#x02009;=&#x02009;15<hr/></td><td colspan="2" align="center" valign="top">N&#x02009;=&#x02009;9<hr/></td><td colspan="2" align="center" valign="top">N&#x02009;=&#x02009;14<hr/></td></tr><tr><td align="center" valign="top">Robust<hr/></td><td align="center" valign="top">3<hr/></td><td align="center" valign="top">20.0<hr/></td><td align="center" valign="top">0<hr/></td><td align="center" valign="top">0.0<hr/></td><td align="center" valign="top">0<hr/></td><td align="center" valign="top">0.0<hr/></td></tr><tr><td align="center" valign="top">Pre-frail<hr/></td><td align="center" valign="top">6<hr/></td><td align="center" valign="top">40.0<hr/></td><td align="center" valign="top">2<hr/></td><td align="center" valign="top">22.2<hr/></td><td align="center" valign="top">3<hr/></td><td align="center" valign="top">21.4<hr/></td></tr><tr><td align="center" valign="top">Frail</td><td align="center" valign="top">6</td><td align="center" valign="top">40.0</td><td align="center" valign="top">7</td><td align="center" valign="top">77.8</td><td align="center" valign="top">11</td><td align="center" valign="top">78.6</td></tr></tbody></table></table-wrap></sec><sec><title>Secondary outcomes</title><sec><title>Individual frailty indicator</title><p>In general, no within or between group differences were observed over repeated measures (Table 
<xref ref-type="table" rid="T4">4</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Follow-up analysis (Intent to treat), Total Patient Number&#x02009;=&#x02009;117</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/><col align="char"/></colgroup><thead valign="top"><tr><th rowspan="2" align="left" valign="top"><bold>Characteristics</bold></th><th align="char" valign="top"><bold>EN (N&#x02009;=&#x02009;55)</bold><hr/></th><th align="char" valign="top"><bold>Non-EN (N&#x02009;=&#x02009;62)</bold><hr/></th><th rowspan="2" align="center" valign="top"><bold>p-value</bold>&#x02021;</th><th align="char" valign="top"><bold>PST (N&#x02009;=&#x02009;57)</bold><hr/></th><th align="char" valign="top"><bold>Non-PST (N&#x02009;=&#x02009;60)</bold><hr/></th><th rowspan="2" align="center" valign="top"><bold>p-value</bold>&#x02021;</th></tr><tr><th align="char" valign="top"><bold>n (%).mean &#x000b1; sd&#x02020;</bold></th><th align="char" valign="top"><bold>n (%) mean &#x000b1; sd&#x02020;</bold></th><th align="char" valign="top"><bold>n (%)mean &#x000b1; sd&#x02020;</bold></th><th align="char" valign="top"><bold>n (%) mean &#x000b1; sd&#x02020;</bold></th></tr></thead><tbody valign="top"><tr><td colspan="7" align="center" valign="top"><bold>Frailty-related Characteristics</bold><hr/></td></tr><tr><td align="left" valign="top">Improvement of CHS_PCF characteristics<sup>&#x000a7;</sup><hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">Weight loss (yes)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 3-month<hr/></td><td align="char" valign="top" char="(">9 (16)<hr/></td><td align="char" valign="top" char="(">6 (10)<hr/></td><td align="char" valign="top" char=".">0.277<hr/></td><td align="char" valign="top" char="(">7 (12)<hr/></td><td align="char" valign="top" char="(">8 (13)<hr/></td><td align="char" valign="top" char=".">0.838<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 6-month<hr/></td><td align="char" valign="top" char="(">8 (15)<hr/></td><td align="char" valign="top" char="(">8 (13)<hr/></td><td align="char" valign="top" char=".">0.761<hr/></td><td align="char" valign="top" char="(">6 (11)<hr/></td><td align="char" valign="top" char="(">10 (17)<hr/></td><td align="char" valign="top" char=".">0.329<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 12-month<hr/></td><td align="char" valign="top" char="(">11 (20)<hr/></td><td align="char" valign="top" char="(">9 (15)<hr/></td><td align="char" valign="top" char=".">0.400<hr/></td><td align="char" valign="top" char="(">8 (14)<hr/></td><td align="char" valign="top" char="(">12 (20)<hr/></td><td align="char" valign="top" char=".">0.372<hr/></td></tr><tr><td align="left" valign="top">Exhaustion (yes)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 3-month<hr/></td><td align="char" valign="top" char="(">16 (29)<hr/></td><td align="char" valign="top" char="(">17 (27)<hr/></td><td align="char" valign="top" char=".">0.824<hr/></td><td align="char" valign="top" char="(">16 (28)<hr/></td><td align="char" valign="top" char="(">17(28)<hr/></td><td align="char" valign="top" char=".">0.968<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 6-month<hr/></td><td align="char" valign="top" char="(">17 (31)<hr/></td><td align="char" valign="top" char="(">18(29)<hr/></td><td align="char" valign="top" char=".">0.806<hr/></td><td align="char" valign="top" char="(">16 (28)<hr/></td><td align="char" valign="top" char="(">19 (42)<hr/></td><td align="char" valign="top" char=".">0.666<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 12-month<hr/></td><td align="char" valign="top" char="(">19 (35)<hr/></td><td align="char" valign="top" char="(">20 (32)<hr/></td><td align="char" valign="top" char=".">0.769<hr/></td><td align="char" valign="top" char="(">16 (28)<hr/></td><td align="char" valign="top" char="(">23 (38)<hr/></td><td align="char" valign="top" char=".">0.328<hr/></td></tr><tr><td align="left" valign="top">Low activity level (yes)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 3-month<hr/></td><td align="char" valign="top" char="(">2(4)<hr/></td><td align="char" valign="top" char="(">4 (6)<hr/></td><td align="char" valign="top" char=".">0.495<hr/></td><td align="char" valign="top" char="(">3(5)<hr/></td><td align="char" valign="top" char="(">3(5)<hr/></td><td align="char" valign="top" char=".">0.926<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 6-month<hr/></td><td align="char" valign="top" char="(">2 (4)<hr/></td><td align="char" valign="top" char="(">4 (6)<hr/></td><td align="char" valign="top" char=".">0.495<hr/></td><td align="char" valign="top" char="(">3 (5)<hr/></td><td align="char" valign="top" char="(">3 (5)<hr/></td><td align="char" valign="top" char=".">0.926<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 12-month<hr/></td><td align="char" valign="top" char="(">2(4)<hr/></td><td align="char" valign="top" char="(">4 (6)<hr/></td><td align="char" valign="top" char=".">0.495<hr/></td><td align="char" valign="top" char="(">3(5)<hr/></td><td align="char" valign="top" char="(">3 (5)<hr/></td><td align="char" valign="top" char=".">0.926<hr/></td></tr><tr><td align="left" valign="top">Slowness (yes)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 3-month<hr/></td><td align="char" valign="top" char="(">6 (11)<hr/></td><td align="char" valign="top" char="(">2 (3)<hr/></td><td align="char" valign="top" char=".">0.126<hr/></td><td align="char" valign="top" char="(">5 (9)<hr/></td><td align="char" valign="top" char="(">3 (5)<hr/></td><td align="char" valign="top" char=".">0.423<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 6-month<hr/></td><td align="char" valign="top" char="(">4 (7)<hr/></td><td align="char" valign="top" char="(">3 (5)<hr/></td><td align="char" valign="top" char=".">0.585<hr/></td><td align="char" valign="top" char="(">6 (11)<hr/></td><td align="char" valign="top" char="(">1 (2)<hr/></td><td align="char" valign="top" char=".">0.085<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 12-month<hr/></td><td align="char" valign="top" char="(">6 (11)<hr/></td><td align="char" valign="top" char="(">3 (5)<hr/></td><td align="char" valign="top" char=".">0.232<hr/></td><td align="char" valign="top" char="(">7 (12)<hr/></td><td align="char" valign="top" char="(">2 (3)<hr/></td><td align="char" valign="top" char=".">0.090<hr/></td></tr><tr><td align="left" valign="top">Weakness (yes)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 3-month<hr/></td><td align="char" valign="top" char="(">11 (20)<hr/></td><td align="char" valign="top" char="(">17 (27)<hr/></td><td align="char" valign="top" char=".">0.346<hr/></td><td align="char" valign="top" char="(">17 (30)<hr/></td><td align="char" valign="top" char="(">11 (18)<hr/></td><td align="char" valign="top" char=".">0.135<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 6-month<hr/></td><td align="char" valign="top" char="(">9 (16)<hr/></td><td align="char" valign="top" char="(">16 (26)<hr/></td><td align="char" valign="top" char=".">0.218<hr/></td><td align="char" valign="top" char="(">9 (16)<hr/></td><td align="char" valign="top" char="(">16 (27)<hr/></td><td align="char" valign="top" char=".">0.170<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Improvement at 12-month<hr/></td><td align="char" valign="top" char="(">7 (13)<hr/></td><td align="char" valign="top" char="(">17 (27)<hr/></td><td align="char" valign="top" char=".">0.055<hr/></td><td align="char" valign="top" char="(">12 (21)<hr/></td><td align="char" valign="top" char="(">12 (20)<hr/></td><td align="char" valign="top" char=".">0.837<hr/></td></tr><tr><td colspan="7" align="center" valign="top"><bold>Health-Related Characteristics</bold><hr/></td></tr><tr><td align="left" valign="top">MMSE<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.15 &#x000b1; 2.53<hr/></td><td align="char" valign="top" char="&#x000b1;">0.06 &#x000b1; 2.52<hr/></td><td align="char" valign="top" char=".">0.658<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.05 &#x000b1; 2.35<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.02 &#x000b1; 2.69<hr/></td><td align="char" valign="top" char=".">0.954<hr/></td></tr><tr><td align="left" valign="top">PRIME-MD<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 3-month<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.96 &#x000b1; 2.92<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;1.29 &#x000b1; 4.50**<hr/></td><td align="char" valign="top" char=".">0.631<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;1.32 &#x000b1; 3.64*<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.97 &#x000b1; 4.03<hr/></td><td align="char" valign="top" char=".">0.603<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 6-month<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.05 &#x000b1; 2.84<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.65 &#x000b1; 4.03<hr/></td><td align="char" valign="top" char=".">0.356<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.42 &#x000b1; 2.96<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.32 &#x000b1; 4.00<hr/></td><td align="char" valign="top" char=".">0.846<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.16 &#x000b1; 3.17<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.77 &#x000b1; 3.65<hr/></td><td align="char" valign="top" char=".">0.327<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.77 &#x000b1; 3.27<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.22 &#x000b1; 3.58<hr/></td><td align="char" valign="top" char=".">0.365<hr/></td></tr><tr><td align="left" valign="top">Barthel Index<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 3-month<hr/></td><td align="char" valign="top" char="&#x000b1;">1.09 &#x000b1; 3.81*<hr/></td><td align="char" valign="top" char="&#x000b1;">1.53 &#x000b1; 4.11**<hr/></td><td align="char" valign="top" char=".">0.520<hr/></td><td align="char" valign="top" char="&#x000b1;">1.05 &#x000b1; 3.98*<hr/></td><td align="char" valign="top" char="&#x000b1;">1.58 &#x000b1; 3.96**<hr/></td><td align="char" valign="top" char=".">0.458<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 6-month<hr/></td><td align="char" valign="top" char="&#x000b1;">0.36 &#x000b1; 2.33<hr/></td><td align="char" valign="top" char="&#x000b1;">0.73 &#x000b1; 4.78<hr/></td><td align="char" valign="top" char=".">0.597<hr/></td><td align="char" valign="top" char="&#x000b1;">0.88 &#x000b1; 4.13<hr/></td><td align="char" valign="top" char="&#x000b1;">0.25 &#x000b1; 3.50<hr/></td><td align="char" valign="top" char=".">0.354<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">0.55 &#x000b1; 2.99<hr/></td><td align="char" valign="top" char="&#x000b1;">0.89 &#x000b1; 3.68<hr/></td><td align="char" valign="top" char=".">0.617<hr/></td><td align="char" valign="top" char="&#x000b1;">0.88 &#x000b1; 3.29<hr/></td><td align="char" valign="top" char="&#x000b1;">0.58 &#x000b1; 3.46<hr/></td><td align="char" valign="top" char=".">0.655<hr/></td></tr><tr><td align="left" valign="top">EQ-5D<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 3-month<hr/></td><td align="char" valign="top" char="&#x000b1;">0.02 &#x000b1; 0.08<hr/></td><td align="char" valign="top" char="&#x000b1;">0.03 &#x000b1; 0.08*<hr/></td><td align="char" valign="top" char=".">0.632<hr/></td><td align="char" valign="top" char="&#x000b1;">0.01 &#x000b1; 0.09<hr/></td><td align="char" valign="top" char="&#x000b1;">0.03 &#x000b1; 0.08**<hr/></td><td align="char" valign="top" char=".">0.162<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 6-month<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.004 &#x000b1; 0.12<hr/></td><td align="char" valign="top" char="&#x000b1;">0.004 &#x000b1; 0.12<hr/></td><td align="char" valign="top" char=".">0.738<hr/></td><td align="char" valign="top" char="&#x000b1;">0.0001 &#x000b1; 0.09<hr/></td><td align="char" valign="top" char="&#x000b1;">0.001 &#x000b1; 0.14<hr/></td><td align="char" valign="top" char=".">0.980<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">0.01 &#x000b1; 0.09<hr/></td><td align="char" valign="top" char="&#x000b1;">0.02 &#x000b1; 0.10<hr/></td><td align="char" valign="top" char=".">0.455<hr/></td><td align="char" valign="top" char="&#x000b1;">0.01 &#x000b1; 0.07<hr/></td><td align="char" valign="top" char="&#x000b1;">0.02 &#x000b1; 0.11<hr/></td><td align="char" valign="top" char=".">0.534<hr/></td></tr><tr><td align="left" valign="top">Healthcare-resource utilization<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 3-month<hr/></td><td align="char" valign="top" char="&#x000b1;">0.04 &#x000b1; 1.36<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.35 &#x000b1; 2.70<hr/></td><td align="char" valign="top" char=".">0.353<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.07 &#x000b1; 1.67<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.27 &#x000b1; 2.58<hr/></td><td align="char" valign="top" char=".">0.650<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 6-month<hr/></td><td align="char" valign="top" char="&#x000b1;">0.60 &#x000b1; 1.81<hr/></td><td align="char" valign="top" char="&#x000b1;">0.03 &#x000b1; 2.55<hr/></td><td align="char" valign="top" char=".">0.186<hr/></td><td align="char" valign="top" char="&#x000b1;">0.42 &#x000b1; 1.74<hr/></td><td align="char" valign="top" char="&#x000b1;">0.18 &#x000b1; 2.65<hr/></td><td align="char" valign="top" char=".">0.589<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">0.05 &#x000b1; 1.8<hr/></td><td align="char" valign="top" char="&#x000b1;">0.03 &#x000b1; 2.44<hr/></td><td align="char" valign="top" char=".">0.984<hr/></td><td align="char" valign="top" char="&#x000b1;">0.39 &#x000b1; 2.05<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.28 &#x000b1; 2.25<hr/></td><td align="char" valign="top" char=".">0.104<hr/></td></tr><tr><td colspan="7" align="center" valign="top"><bold>Body Composition, and Musculoskeletal System Characteristics</bold><hr/></td></tr><tr><td align="left" valign="top">BMI (kg/m<sup>2</sup>)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.31 &#x000b1; 1.19*<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.18 &#x000b1; 1.05<hr/></td><td align="char" valign="top" char=".">0.572<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.36 &#x000b1; 1.15*<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.13 &#x000b1; 1.08<hr/></td><td align="char" valign="top" char=".">0.280<hr/></td></tr><tr><td align="left" valign="top">FFM (kg)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.46 &#x000b1; 1.36*<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.62 &#x000b1; 1.84**<hr/></td><td align="char" valign="top" char=".">0.587<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.59 &#x000b1; 1.30**<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;0.50 &#x000b1; 1.90*<hr/></td><td align="char" valign="top" char=".">0.726<hr/></td></tr><tr><td align="left" valign="top">Compression Fracture form Spine X-ray<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;12-month<hr/></td><td align="char" valign="top" char="(">55(100)<hr/></td><td align="char" valign="top" char="(">58(94)<hr/></td><td align="char" valign="top" char=".">0.137<hr/></td><td align="char" valign="top" char="(">54 (95)<hr/></td><td align="char" valign="top" char="(">59(98)<hr/></td><td align="char" valign="top" char=".">0.518<hr/></td></tr><tr><td align="left" valign="top">BMD (T-score)<sup>&#x02225;</sup> (N&#x02009;=&#x02009;115)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">12-month<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;&#x0003e; &#x02212;1<hr/></td><td align="char" valign="top" char="(">14(26)<hr/></td><td align="char" valign="top" char="(">7(11)<hr/></td><td align="char" valign="top" char=".">0.042<hr/></td><td align="char" valign="top" char="(">11(20)<hr/></td><td align="char" valign="top" char="(">10(17)<hr/></td><td align="char" valign="top" char=".">0.770<hr/></td></tr><tr><td align="left" valign="top">&#x02002;&#x02266; &#x02212;1<hr/></td><td align="char" valign="top" char="(">39(74)<hr/></td><td align="char" valign="top" char="(">55(89)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top" char="(">45(80)<hr/></td><td align="char" valign="top" char="(">49 (83)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">Left one leg stand time (sec) (N&#x02009;=&#x02009;111)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 3-month<hr/></td><td align="char" valign="top" char="&#x000b1;">2.86 &#x000b1; 9.19*<hr/></td><td align="char" valign="top" char="&#x000b1;">0.92 &#x000b1; 9.01<hr/></td><td align="char" valign="top" char=".">0.268<hr/></td><td align="char" valign="top" char="&#x000b1;">2.38 &#x000b1; 8.91<hr/></td><td align="char" valign="top" char="&#x000b1;">1.34 &#x000b1; 9.34<hr/></td><td align="char" valign="top" char=".">0.553<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 6-month<hr/></td><td align="char" valign="top" char="&#x000b1;">2.57 &#x000b1; 8.39*<hr/></td><td align="char" valign="top" char="&#x000b1;">1.81 &#x000b1; 8.47<hr/></td><td align="char" valign="top" char=".">0.683<hr/></td><td align="char" valign="top" char="&#x000b1;">3.10 &#x000b1; 8.93*<hr/></td><td align="char" valign="top" char="&#x000b1;">1.30 &#x000b1; 7.84<hr/></td><td align="char" valign="top" char=".">0.298<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">3.69 &#x000b1; 9.15**<hr/></td><td align="char" valign="top" char="&#x000b1;">3.43 &#x000b1;9.15**<hr/></td><td align="char" valign="top" char=".">0.906<hr/></td><td align="char" valign="top" char="&#x000b1;">4.31 &#x000b1; 10.23***<hr/></td><td align="char" valign="top" char="&#x000b1;">2.84 &#x000b1; 7.92*<hr/></td><td align="char" valign="top" char=".">0.399<hr/></td></tr><tr><td align="left" valign="top">Dominant leg extension power (kg)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 3-month<hr/></td><td align="char" valign="top" char="&#x000b1;">3.06 &#x000b1; 7.13**<hr/></td><td align="char" valign="top" char="&#x000b1;">1.72 &#x000b1; 6.6*<hr/></td><td align="char" valign="top" char=".">0.330<hr/></td><td align="char" valign="top" char="&#x000b1;">3.42 &#x000b1; 7.36***<hr/></td><td align="char" valign="top" char="&#x000b1;">1.33 &#x000b1; 6.32<hr/></td><td align="char" valign="top" char=".">0.102<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 6-month<hr/></td><td align="char" valign="top" char="&#x000b1;">1.48 &#x000b1; 5.9<hr/></td><td align="char" valign="top" char="&#x000b1;">1.35 &#x000b1; 7.00<hr/></td><td align="char" valign="top" char=".">0.986<hr/></td><td align="char" valign="top" char="&#x000b1;">2.71 &#x000b1; 6.08**<hr/></td><td align="char" valign="top" char="&#x000b1;">0.18 &#x000b1; 6.68<hr/></td><td align="char" valign="top" char=".">0.035<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;6.44 &#x000b1; 10.08***<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;4.44 &#x000b1; 8.59***<hr/></td><td align="char" valign="top" char=".">0.217<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;3.52 &#x000b1; 9.65**<hr/></td><td align="char" valign="top" char="&#x000b1;">&#x02212;7.14 &#x000b1; 8.74***<hr/></td><td align="char" valign="top" char=".">0.036<hr/></td></tr><tr><td colspan="7" align="center" valign="top"><bold>Blood Examination</bold><hr/></td></tr><tr><td align="left" valign="top">25(OH) Vitamin D (ng/mL) (N&#x02009;=&#x02009;109)<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td><td align="char" valign="top">&#x000a0;<hr/></td></tr><tr><td align="left" valign="top">&#x02002;Change at 12-month</td><td align="char" valign="top" char="&#x000b1;">4.85 &#x000b1; 7.69***</td><td align="char" valign="top" char="&#x000b1;">1.19 &#x000b1; 5.41</td><td align="char" valign="top" char=".">0.006</td><td align="char" valign="top" char="&#x000b1;">3.4 &#x000b1; 7.80***</td><td align="char" valign="top" char="&#x000b1;">2.49 &#x000b1; 5.85**</td><td align="char" valign="top" char=".">0.633</td></tr></tbody></table><table-wrap-foot><p>*P-value&#x02009;&#x0003c;&#x02009;0.05, ** p-value&#x02009;&#x0003c;&#x02009;0.01, *** p-value&#x02009;&#x0003c;&#x02009;0.001 for the comparison of the value at the follow-up time with the baseline value within the group, as calculated with the use of linear mixed model.</p><p>&#x02020;:Categorical data:n (%);Continuous variables:mean <bold>&#x000b1;</bold> sd.</p><p>&#x02021;: Intervention effect, controlling for the other treatment strategy, follow up time and treatment-by-follow up time interactions. Categorical data:generalized estimating equations (<italic>GEE</italic>);Continuous variables:linear mixed model. P-values for compression fracture form spine XRAY and BMD from logistic regression model with exact modification when appropriate.</p><p><sup>&#x000a7;</sup>:After intervention 3, 6 and 12&#x02009;months[<italic>CHS_PCF</italic>]has progressed from[yes]to[no].</p><p><sup>&#x000b6;</sup>:Emergency room visits, hospitalizations, or clinic visits in the past 3&#x02009;months.</p><p><sup>&#x02225;</sup>:The minimum T-score of either the femoral neck or the spinal mean at L2&#x02013;L4.</p><p><italic>BMD</italic>:Bone Mineral Density, <italic>BMI</italic>: Body mass index, <italic>CHS_PCF</italic>: Cardiovascular Health Study_Phenotypical Classification of Frailty, <italic>EN</italic>:Exercise and Nutrition, <italic>EQ</italic>-5D:EuroQol Quality of Life Scale, <italic>FFM</italic>: Fat Free Mass, <italic>MMSE</italic>: Mini-Mental State Examination, <italic>PRIME-MD</italic>: Primary Care Evaluation of Mental Disorders, <italic>PST</italic>: Problem Solving Therapy.</p></table-wrap-foot></table-wrap></sec><sec><title>Health-related characteristics</title><p>There were no observable between group changes. However, within group improvements were found for PRIME-MD (non-EN and PST group at 3-month), BI (all 4 groups at 3-month), and EQ-5D (non-EN and non-PST group at 3-month) (Table 
<xref ref-type="table" rid="T4">4</xref>).</p></sec><sec><title>Body composition, and musculoskeletal system characteristics</title><p>In general, there were no observable between group differences except that changes of dominant leg extension power at 6 and 12&#x02009;months were in favor of the PST group (both p&#x02009;&#x0003c;&#x02009;0.05). At 12&#x02009;month, BMI decreased in both EN and PST group, but not the non-EN or non-PST group. However, FFM decreased in all 4 groups. For one leg stand time and leg extension power, changes at different time periods were general more obvious in intervention (EN or PST) than control (non-EN, non-PST) groups (Table 
<xref ref-type="table" rid="T4">4</xref>).</p></sec><sec><title>Blood test</title><p>Increase of 25 (OH) Vitamin D level was observed in EN, PST, and non-PST groups in 12&#x02009;months. The difference between EN and non-EN group (4.9&#x02009;&#x000b1;&#x02009;7.7 vs 1.2&#x02009;&#x000b1;&#x02009;5.4, p&#x02009;=&#x02009;0.006) was statistically significant (Table 
<xref ref-type="table" rid="T4">4</xref>).</p></sec><sec><title>Interaction</title><p>Interactions between EN and PST were found for improvement of weight loss and 25 (OH) Vitamin D. Controlling the effect of PST, the effect of EN was more significant in EN/non-PST subgroup (weight loss), and EN/PST subgroup (25 (OH) Vitamin D)(Additional file 
<xref ref-type="supplementary-material" rid="S1">1</xref>: Table S1). Controlling for the effect of EN, the effect of PST was more significant in PST/EN subgroup (for both variables) (Additional file 
<xref ref-type="supplementary-material" rid="S2">2</xref>: Table S2).</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Our study demonstrates that the three-month exercise and nutritional program resulted in short-term (3-month) frailty status improvement and long-term effect on BMD and serum 25 OH Vitamin D (12-month) among a population-representative sample of frail older adults. The effect of PST on geriatric frailty, mood, and physical performance was less pronounce. We also found some significant improvements in the control (non-EN, non-PST) groups.</p><p>Many instruments were created to measure frailty and studies with different instruments were difficult to compare with 
[<xref ref-type="bibr" rid="B24">24</xref>]. We chose several recent intervention trials that used modified CHS_PCF for comparison 
[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. Peterson et al. enrolled 81 older male veterans scored &#x02265;1 on CHS_PCF. Roughly half (N&#x02009;=&#x02009;39) were randomized into a high intensity physical activity telephone counseling group 
[<xref ref-type="bibr" rid="B7">7</xref>]. After 6-months, 49% and 69% were still classified as frail respectively (p&#x02009;=&#x02009;0.08). Kenny and colleague reported the effect of 12-month transdermal testosterone patch on 131 older men with low testosterone level, fracture, or low BMD and scored &#x02265;1 on CHS_PCF 
[<xref ref-type="bibr" rid="B6">6</xref>]. Improvements of BMD, and lean mass were found, but not physical performance or frailty indicators 
[<xref ref-type="bibr" rid="B6">6</xref>]. In another RCT, Li et al. enrolled 310 community-dwelling older adults who scored &#x02265;1 on the CHS_PCF 
[<xref ref-type="bibr" rid="B8">8</xref>]. The 6-month individualized multi-factorial care plans after comprehensive geriatric assessments (CGAs) did not improve frailty status. The Frailty Intervention Trial (FIT) 
[<xref ref-type="bibr" rid="B2">2</xref>] used similar CGA with individualized care plans approach but enrolled older adults with &#x02265;3 deficiencies; that study is still in progress and so still lacks published outcome data. To our knowledge, ours is the first study to demonstrate that the CHS_PCF categorization is responsive to intervention to with sound clinimetric properties as an outcome measure 
[<xref ref-type="bibr" rid="B24">24</xref>].</p><p>When other frailty indicators were considered, several recent reviews found that structured exercise improved physical and psychological determinants, frailty status, and prevented disability in frail older adults 
[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. However, many researchers called for more unified definition and operationalization of frailty to enhance comparability of different intervention trials 
[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B27">27</xref>].</p><p>Expert opinions and the results of clinical trials suggest nutritional consultation as a component in frailty interventions 
[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]; but rarely does it stand as an independent intervention on frailty. One recent study showed that diet and exercise was more effective than diet or exercise alone in improving frailty indicators among 93 obese and frail older adults 
[<xref ref-type="bibr" rid="B29">29</xref>]. Our study also added new evidence that combination of exercise program and nutritional information had positive impact on frailty.</p><p>It is not clear whether exercise and/or nutritional consultation has a positive impact on BMD or 25 (OH) Vitamin D level among frail older adults. In a study of 65 subjects randomized to moderate-intensity on-site exercise training 3 times per week for 9&#x02009;months,, the subjects&#x02019; BMD did not differ from that of 47 subjects randomized to a low-intensity home exercise program 
[<xref ref-type="bibr" rid="B30">30</xref>]. Similar to our study, Villareal and colleagues reported positive effect of diet and exercise on improving or preserving BMD from 2 RCTs of 27 
[<xref ref-type="bibr" rid="B31">31</xref>] and 93 
[<xref ref-type="bibr" rid="B29">29</xref>] obese older adults. This research group 
[<xref ref-type="bibr" rid="B31">31</xref>] also found that diet and exercise increased the serum 25(OH) Vitamin D level as in our study.</p><p>In our study, subjects in the PST group had better improvement in frailty and PRIME-MD scores than subjects in the non-PST group; but the differences did not reach statistical significance. Even roughly 40% reported exhaustion from the (CES-D) 
[<xref ref-type="bibr" rid="B32">32</xref>] questions, their mean PRIME-MD score was quite low (average 2 points) indicating low level of depression. The floor effect might explain parts of the lack of effectiveness of PST.</p><p>Some observational studies suggested that frailty is a dynamic process and natural transitions to better status may occur without interventions 
[<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B35">35</xref>]. During the intervention period, our degrees of improvement in frailty status were significantly higher than the natural improvement rates reported from observational studies 
[<xref ref-type="bibr" rid="B34">34</xref>]. On the other hand, the improvement rates during the follow up periods were similar to other studies 
[<xref ref-type="bibr" rid="B34">34</xref>]. It was encouraging that frailty status could be reversed with proper interventions. However, the effects might not last long when intensive interventions were discontinued.</p><p>We felt it unethical to enroll older adults in the control group without basic education material to teach them about self-managements even this might mitigate intervention effect. It is encouraging that subjects received education material only also had improvements in functional status, mood, quality of life, and physical performance.</p><sec><title>Strengths and limitations of the current study</title><p>The probability sampling design enhances the generalizability of this study to community-dwelling frail older adults without significant cognitive or functional impairments. The quick and valid CCSHA_CFS TV saved us tremendous time and resources in conducting the large-scale community-based frailty screening. Our educational material and interventions would be easily replicable in other settings.</p><p>The study also has several important limitations. First, we encountered an unexpectedly low response rate during the telephone-interview stage, with one-third not being reachable after multiple attempts, and another one-third refusing the telephone interviews, which hampers the external validity of the current study.</p><p>Second, compliance with the thrice-weekly exercise sessions and PST sessions were fair. Many participants had problems reaching the study site and other personal issues, such as taking care of their grandchildren which prevented them from on-site intervention. The intervention effect could have been enhanced if better adherence had been reached.</p><p>Third, the CHS_PCF instrument does not allow assessment of different degrees of frailty as the CCSHA_CFS_TV. However, we were not able to detect more subtle changes frailty degrees with the later instrument since it was only used at the screening stage.</p><p>Forth, we did not have use population specific cut-points in the 5 frailty indicators to enroll study participants. At the time of the study design, Taiwanese frailty cut-points with the CHS_PCF were not available. However, since it is an interventional study with a purpose to identify subjects with certain degree of frailty suitable for interventions, it probabably did not matter which cut-points were used as long as study populations could be clearly and systemicly identified and classified.</p><p>Finally, the study sample size is relatively small, though it is comparable or greater than some previous interventional studies of frailty 
[<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B31">31</xref>]. In the review conducted by Thou and colleagues 
[<xref ref-type="bibr" rid="B4">4</xref>], only 13 out of 47 exercise programs had sample size greater than our study which indicating the difficulty enrolling and conducting RCTs in frail older adults. Since there was a lack of previous data to guide estimation of sample size based on our designated primary outcome, one purpose of this study was to determine feasible sample size for future study.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In summary, with proper exercise and nutritional management even a short, 3-month intervention can improve the dynamic frailty process, bone mineral density, and 25(OH) Vitamin D level in frail older adults.</p></sec><sec><title>Competing interests</title><p>All authors do not have competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>All of the authors participated in the preparation of the manuscript. Specifically, D-C D C, R-S Y, and J-Y T wrote the first draft of the manuscript. H-H T and C A H performed statistical analysis and wrote the analysis section. C-Y C and K N K designed the study and provided substantial revisions to the manuscript. All authors have read and approved the final manuscript.</p></sec><sec><title>Authors&#x02019; information</title><p>All authors had access to the data and had a role in writing the manuscript.</p></sec><sec><title>Funding</title><p>This work was supported by the National Health Research Institutes, Zhunan, Taiwan grant (97-HD-SP-08 &#x0201c;Interventional Study of Geriatric Frailty, Osteoporosis, and Depression in a Community Based Randomized Trial&#x0201d;).</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2318/12/58/prepub">http://www.biomedcentral.com/1471-2318/12/58/prepub</ext-link></p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Table S1.</bold> Follow-up analysis (Intent to treat), Total Patient Number=117. (Interactions between EN and PST were found for improvement of weight loss and 25 (OH) Vitamin D. Table 2s_1:EN vs. non-EN, controlling for PST or non-PST).</p></caption><media xlink:href="1471-2318-12-58-S1.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>Table S2.</bold> Follow-up analysis (Intent to treat), Total Patient Number=117. (Interactions between EN and PST were found for improvement of weight loss and 25 (OH) Vitamin D. Table 2s_2:PST vs. non-PST, controlling for EN or non-EN).</p></caption><media xlink:href="1471-2318-12-58-S2.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Rockwood</surname><given-names>K</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>MacKnight</surname><given-names>C</given-names></name><etal/><article-title>A global clinical measure of fitness and frailty in elderly people</article-title><source>CMAJ</source><year>2005</year><volume>173</volume><fpage>489</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1503/cmaj.050051</pub-id><pub-id pub-id-type="pmid">16129869</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Fairhall</surname><given-names>N</given-names></name><name><surname>Aggar</surname><given-names>C</given-names></name><name><surname>Kurrle</surname><given-names>SE</given-names></name><etal/><article-title>Frailty Intervention Trial (FIT)</article-title><source>BMC Geriatr</source><year>2008</year><volume>8</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.1186/1471-2318-8-27</pub-id><pub-id pub-id-type="pmid">18851754</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Mezuk</surname><given-names>B</given-names></name><name><surname>Edwards</surname><given-names>L</given-names></name><name><surname>Lohman</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Lapane</surname><given-names>K</given-names></name><article-title>Depression and frailty in later life: a synthetic review</article-title><source>Int J Geriatr Psychiatry</source><year>2012</year><volume>27</volume><issue>9</issue><fpage>879</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1002/gps.2807</pub-id><pub-id pub-id-type="pmid">21984056</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="other"><name><surname>Theou</surname><given-names>O</given-names></name><name><surname>Stathokostas</surname><given-names>L</given-names></name><name><surname>Roland</surname><given-names>KP</given-names></name><etal/><article-title>The effectiveness of exercise interventions for the management of frailty: a systematic review</article-title><source>J Aging Res</source><volume>2011</volume><fpage>19</fpage><comment>article ID 569194</comment></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>PH</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name><article-title>Interventions targeting geriatric frailty: a systemic review</article-title><source>J Clinic Geriatr Gerontol</source><year>2012</year><volume>3</volume><issue>2</issue><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.jcgg.2012.04.001</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Kenny</surname><given-names>AM</given-names></name><name><surname>Kleppinger</surname><given-names>A</given-names></name><name><surname>Annis</surname><given-names>K</given-names></name><etal/><article-title>Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty</article-title><source>J Am Geriatr Soc</source><year>2010</year><volume>58</volume><fpage>1134</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2010.02865.x</pub-id><pub-id pub-id-type="pmid">20722847</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Peterson</surname><given-names>MJ</given-names></name><name><surname>Sloane</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>HJ</given-names></name><name><surname>Crowley</surname><given-names>GM</given-names></name><name><surname>Pieper</surname><given-names>CF</given-names></name><name><surname>Morey</surname><given-names>MC</given-names></name><article-title>Effect of telephone exercise counseling on frailty in older veterans: project LIFE</article-title><source>Am J Mens Health</source><year>2007</year><volume>1</volume><fpage>326</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1177/1557988307306153</pub-id><pub-id pub-id-type="pmid">19482814</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>CM</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Li</surname><given-names>CY</given-names></name><name><surname>Wang</surname><given-names>WD</given-names></name><name><surname>Wu</surname><given-names>SC</given-names></name><article-title>The effectiveness of a comprehensive geriatric assessment intervention program for frailty in community-dwelling older people: a randomized, controlled trial</article-title><source>Arch Gerontol Geriatr</source><year>2010</year><volume>50</volume><issue>Suppl 1</issue><fpage>S39</fpage><lpage>S42</lpage><pub-id pub-id-type="pmid">20171455</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Fried</surname><given-names>LP</given-names></name><name><surname>Tangen</surname><given-names>CM</given-names></name><name><surname>Walston</surname><given-names>J</given-names></name><etal/><article-title>Frailty in older adults: evidence for a phenotype</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2001</year><volume>56</volume><fpage>M146</fpage><lpage>M156</lpage><pub-id pub-id-type="doi">10.1093/gerona/56.3.M146</pub-id><pub-id pub-id-type="pmid">11253156</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="book"><name><surname>Fried</surname><given-names>LP</given-names></name><name><surname>Walston</surname><given-names>JD</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><etal/><person-group person-group-type="editor">Halter JB</person-group><article-title>Frailty</article-title><source>Hazzard's Geriatric Medicine and Gerontology</source><year>2009</year><edition>SIXTH</edition><publisher-name>McGrall-Hill, New York</publisher-name><fpage>631</fpage><lpage>645</lpage></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Olde Rikkert</surname><given-names>MG</given-names></name><name><surname>Rigaud</surname><given-names>AS</given-names></name><name><surname>van Hoeyweghen</surname><given-names>RJ</given-names></name><name><surname>de Graaf</surname><given-names>J</given-names></name><article-title>Geriatric syndromes: medical misnomer or progress in geriatrics?</article-title><source>Neth J Med</source><year>2003</year><volume>61</volume><fpage>83</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12765229</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="other"><name><surname>Vermeulen</surname><given-names>J</given-names></name><name><surname>Neyens</surname><given-names>JC</given-names></name><name><surname>van Rossum</surname><given-names>E</given-names></name><name><surname>Spreeuwenberg</surname><given-names>MD</given-names></name><name><surname>de Witte</surname><given-names>LP</given-names></name><article-title>Predicting ADL disability in community-dwelling elderly people using physical frailty indicators: a systematic review</article-title><source>BMC geriatrics</source><volume>11</volume><fpage>33</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">21722355</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>CI</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name><name><surname>Kuo</surname><given-names>KN</given-names></name><name><surname>Hsiung</surname><given-names>CA</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><article-title>Vitamin D insufficiency and frailty syndrome in older adults living in a Northern Taiwan community</article-title><source>Arch Gerontol Geriatr</source><year>2010</year><volume>50</volume><issue>Suppl 1</issue><fpage>S17</fpage><lpage>S21</lpage><pub-id pub-id-type="pmid">20171450</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Rolland</surname><given-names>Y</given-names></name><name><surname>Abellan van Kan</surname><given-names>G</given-names></name><name><surname>Benetos</surname><given-names>A</given-names></name><etal/><article-title>Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives</article-title><source>J Nutr Health Aging</source><year>2008</year><volume>12</volume><issue>5</issue><fpage>335</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">18443717</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="other"><name><surname>Clegg</surname><given-names>A</given-names></name><name><surname>Barber</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>J</given-names></name><name><surname>Forster</surname><given-names>A</given-names></name><name><surname>Iliffe</surname><given-names>S</given-names></name><article-title>The Home-Based Older People's Exercise (HOPE) trial: study protocol for a randomised controlled trial</article-title><source>Trials</source><volume>12</volume><fpage>143</fpage><pub-id pub-id-type="pmid">21651805</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>DC</given-names></name><name><surname>Tsou</surname><given-names>HH</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><article-title>Validation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone version</article-title><source>Arch Gerontol Geriatr</source><year>2010</year><volume>50</volume><fpage>e74</fpage><lpage>e80</lpage><pub-id pub-id-type="doi">10.1016/j.archger.2009.06.004</pub-id><pub-id pub-id-type="pmid">19608288</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="book"><name><surname>Liu</surname><given-names>YM</given-names></name><source>Validation of the Taiwan International Physical Activity Questionnaire-Short Form (Doctoral Dissertation in Chinese)</source><year>2004</year><publisher-name>National Taiwan University, Taipei</publisher-name></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Taylor</surname><given-names>HL</given-names></name><name><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name><surname>Schucker</surname><given-names>B</given-names></name><name><surname>Knudsen</surname><given-names>J</given-names></name><name><surname>Leon</surname><given-names>AS</given-names></name><name><surname>Debacker</surname><given-names>G</given-names></name><article-title>A questionnaire for the assessment of leisure time physical activities</article-title><source>J Chronic Dis</source><year>1978</year><volume>31</volume><fpage>741</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1016/0021-9681(78)90058-9</pub-id><pub-id pub-id-type="pmid">748370</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Folstein</surname><given-names>MF</given-names></name><name><surname>Folstein</surname><given-names>SE</given-names></name><name><surname>McHugh</surname><given-names>PR</given-names></name><article-title>"Mini-mental state". a practical method for grading the cognitive state of patients for the clinician</article-title><source>J Psychiatr Res</source><year>1975</year><volume>12</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/0022-3956(75)90026-6</pub-id><pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Mahoney</surname><given-names>FI</given-names></name><name><surname>Barthel</surname><given-names>DW</given-names></name><article-title>Functional evaluation: the barthel index</article-title><source>Md State Med J</source><year>1965</year><volume>14</volume><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">14258950</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Kroenke</surname><given-names>K</given-names></name><etal/><article-title>Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study</article-title><source>Jama</source><year>1994</year><volume>272</volume><fpage>1749</fpage><lpage>1756</lpage><pub-id pub-id-type="doi">10.1001/jama.1994.03520220043029</pub-id><pub-id pub-id-type="pmid">7966923</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>TJ</given-names></name><name><surname>Tarn</surname><given-names>YH</given-names></name><name><surname>Hsieh</surname><given-names>CL</given-names></name><name><surname>Liou</surname><given-names>WS</given-names></name><name><surname>Shaw</surname><given-names>JW</given-names></name><name><surname>Chiou</surname><given-names>XG</given-names></name><article-title>Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population</article-title><source>J Formos Med Assoc</source><year>2007</year><volume>106</volume><fpage>1023</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/S0929-6646(08)60078-9</pub-id><pub-id pub-id-type="pmid">18194908</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Malouff</surname><given-names>JM</given-names></name><name><surname>Thorsteinsson</surname><given-names>EB</given-names></name><name><surname>Schutte</surname><given-names>NS</given-names></name><article-title>The efficacy of problem solving therapy in reducing mental and physical health problems: a meta-analysis</article-title><source>Clin Psychol Rev</source><year>2007</year><volume>27</volume><fpage>46</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.cpr.2005.12.005</pub-id><pub-id pub-id-type="pmid">16480801</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>de Vries</surname><given-names>NM</given-names></name><name><surname>Staal</surname><given-names>JB</given-names></name><name><surname>van Ravensberg</surname><given-names>CD</given-names></name><name><surname>Hobbelen</surname><given-names>JS</given-names></name><name><surname>Olde Rikkert</surname><given-names>MG</given-names></name><name><surname>Nijhuis-van der Sanden</surname><given-names>MW</given-names></name><article-title>Outcome instruments to measure frailty: a systematic review</article-title><source>Ageing Res Rev</source><year>2011</year><volume>10</volume><fpage>104</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2010.09.001</pub-id><pub-id pub-id-type="pmid">20850567</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Chin</surname><given-names>APMJ</given-names></name><name><surname>van Uffelen</surname><given-names>JG</given-names></name><name><surname>Riphagen</surname><given-names>I</given-names></name><name><surname>van Mechelen</surname><given-names>W</given-names></name><article-title>The functional effects of physical exercise training in frail older people: a systematic review</article-title><source>Sports Med</source><year>2008</year><volume>38</volume><fpage>781</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.2165/00007256-200838090-00006</pub-id><pub-id pub-id-type="pmid">18712944</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Daniels</surname><given-names>R</given-names></name><name><surname>van Rossum</surname><given-names>E</given-names></name><name><surname>de Witte</surname><given-names>L</given-names></name><name><surname>Kempen</surname><given-names>GI</given-names></name><name><surname>van den Heuvel</surname><given-names>W</given-names></name><article-title>Interventions to prevent disability in frail community-dwelling elderly: a systematic review</article-title><source>BMC Health Serv Res</source><year>2008</year><volume>8</volume><fpage>278</fpage><pub-id pub-id-type="doi">10.1186/1472-6963-8-278</pub-id><pub-id pub-id-type="pmid">19115992</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Gobbens</surname><given-names>RJ</given-names></name><name><surname>Luijkx</surname><given-names>KG</given-names></name><name><surname>Wijnen-Sponselee</surname><given-names>MT</given-names></name><name><surname>Schols</surname><given-names>JM</given-names></name><article-title>Toward a conceptual definition of frail community dwelling older people</article-title><source>Nurs Outlook</source><year>2010</year><volume>58</volume><fpage>76</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.outlook.2009.09.005</pub-id><pub-id pub-id-type="pmid">20362776</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Villareal</surname><given-names>DT</given-names></name><name><surname>Banks</surname><given-names>M</given-names></name><name><surname>Sinacore</surname><given-names>DR</given-names></name><name><surname>Siener</surname><given-names>C</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name><article-title>Effect of weight loss and exercise on frailty in obese older adults</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>860</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1001/archinte.166.8.860</pub-id><pub-id pub-id-type="pmid">16636211</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Villareal</surname><given-names>DT</given-names></name><name><surname>Chode</surname><given-names>S</given-names></name><name><surname>Parimi</surname><given-names>N</given-names></name><etal/><article-title>Weight loss, exercise, or both and physical function in obese older adults</article-title><source>N Engl J Med</source><year>2011</year><volume>364</volume><fpage>1218</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1008234</pub-id><pub-id pub-id-type="pmid">21449785</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Villareal</surname><given-names>DT</given-names></name><name><surname>Steger-May</surname><given-names>K</given-names></name><name><surname>Schechtman</surname><given-names>KB</given-names></name><etal/><article-title>Effects of exercise training on bone mineral density in frail older women and men: a randomised controlled trial</article-title><source>Age Ageing</source><year>2004</year><volume>33</volume><fpage>309</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1093/ageing/afh044</pub-id><pub-id pub-id-type="pmid">15082440</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Villareal</surname><given-names>DT</given-names></name><name><surname>Shah</surname><given-names>K</given-names></name><name><surname>Banks</surname><given-names>MR</given-names></name><name><surname>Sinacore</surname><given-names>DR</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name><article-title>Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial</article-title><source>J Clin Endocrinol Metab</source><year>2008</year><volume>93</volume><fpage>2181</fpage><lpage>2187</lpage><pub-id pub-id-type="doi">10.1210/jc.2007-1473</pub-id><pub-id pub-id-type="pmid">18364384</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="other"><name><surname>Radloff</surname><given-names>LS</given-names></name><article-title>The CES-D scale: a self-report depression scale for research in the general population</article-title><source>Appl Psychol Meas</source><volume>1977</volume><issue>1</issue><fpage>385</fpage><lpage>401</lpage></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Fallah</surname><given-names>N</given-names></name><name><surname>Mitnitski</surname><given-names>A</given-names></name><name><surname>Searle</surname><given-names>SD</given-names></name><name><surname>Gahbauer</surname><given-names>EA</given-names></name><name><surname>Gill</surname><given-names>TM</given-names></name><name><surname>Rockwood</surname><given-names>K</given-names></name><article-title>Transitions in frailty status in older adults in relation to mobility: a multistate modeling approach employing a deficit count</article-title><source>J Am Geriatr Soc</source><year>2011</year><volume>59</volume><fpage>524</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2011.03300.x</pub-id><pub-id pub-id-type="pmid">21391943</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Gill</surname><given-names>TM</given-names></name><name><surname>Gahbauer</surname><given-names>EA</given-names></name><name><surname>Allore</surname><given-names>HG</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><article-title>Transitions between frailty states among community-living older persons</article-title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>418</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">16505261</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Gill</surname><given-names>TM</given-names></name><name><surname>Gahbauer</surname><given-names>EA</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Allore</surname><given-names>HG</given-names></name><article-title>The relationship between intervening hospitalizations and transitions between frailty States</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2011</year><volume>66</volume><fpage>1238</fpage><lpage>1243</lpage><pub-id pub-id-type="pmid">21852286</pub-id></mixed-citation></ref></ref-list></back></article>